NPPA notified regarding the fixation of the retail price of Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Glimepiride IP 1 mg + Metformin Hydrochloride IP 500mg

Oct 04, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00

Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on October 03, 2024, notified regarding the fixation of the retail price of Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Glimepiride IP 1 mg + Metformin Hydrochloride IP 500mg.

The following has been stated namely: -

• It has fixed the rate at Rs. 12.42/- for the Composition of each film-coated bilayered tablet Containing: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Glimepiride IP 1 mg + Metformin Hydrochloride IP 500mg.

[Notification no. - 19(4229)/2024/DP/NPPA/Div.II]

View Document 1

Bookmark

Related Updates

View More Related Updates


Alternate Text

Get updates on the go on RegUpdate Mobile App.

Alternate Text
✦ NEW  ·  AI ASSISTANT